ProMIS Neurosciences, Inc. (PMN)
13.07
-0.90
(-6.48%)
USD |
NASDAQ |
Sep 03, 16:00
13.07
0.00 (0.00%)
After-Hours: 20:00
ProMIS Neurosciences Total Liabilities (Quarterly) : 7.295M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.295M |
| March 31, 2026 | 6.694M |
| December 31, 2025 | 10.44M |
| September 30, 2025 | 12.27M |
| June 30, 2025 | 9.892M |
| March 31, 2025 | 4.175M |
| December 31, 2024 | 2.423M |
| September 30, 2024 | 17.24M |
| June 30, 2024 | 3.687M |
| March 31, 2024 | 3.471M |
| December 31, 2023 | 9.866M |
| September 30, 2023 | 11.12M |
| June 30, 2023 | 10.03M |
| March 31, 2023 | 10.61M |
| December 31, 2022 | 8.272M |
| September 30, 2022 | 4.652M |
| June 30, 2022 | 3.479M |
| March 31, 2022 | 10.70M |
| December 31, 2021 | 11.86M |
| September 30, 2021 | 15.47M |
| June 30, 2021 | 13.43M |
| March 31, 2021 | 14.38M |
| December 31, 2020 | 1.884M |
| September 30, 2020 | 2.056M |
| June 30, 2020 | 1.520M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.242M |
| December 31, 2019 | 1.292M |
| September 30, 2019 | 1.297M |
| June 30, 2019 | 0.741M |
| March 31, 2019 | 0.5787M |
| December 31, 2018 | 1.325M |
| September 30, 2018 | 0.5834M |
| June 30, 2018 | 0.3594M |
| March 31, 2018 | 0.1994M |
| December 31, 2017 | 0.5088M |
| September 30, 2017 | 0.7287M |
| June 30, 2017 | 0.7651M |
| March 31, 2017 | 0.457M |
| December 31, 2016 | 0.6699M |
| September 30, 2016 | 0.5022M |
| June 30, 2016 | 0.4057M |
| March 31, 2016 | 0.4481M |
| December 31, 2015 | 0.3965M |
| September 30, 2015 | 0.3979M |
| June 30, 2015 | 0.9226M |
| March 31, 2015 | 0.6595M |
| December 31, 2014 | 0.4254M |
| September 30, 2014 | 0.3764M |
| June 30, 2014 | 0.2716M |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 3.91M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.69M |
| Shareholders Equity (Quarterly) | 49.40M |
| Current Ratio | 7.855 |